HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carbohydrate-deficient transferrin depends on disease activity in rheumatoid arthritis and systemic sclerosis.

AbstractOBJECTIVES:
Changes in the glycosylation of plasma proteins have been linked to the aetiology of the rheumatic diseases. The aim of this study was to determine and compare the levels of carbohydrate-deficient transferrin (CDT) in patients with rheumatoid arthritis (RA), systemic sclerosis (SSc), and systemic lupus erythematosus (SLE).
METHOD:
Studies were carried out in 29 female patients with RA, 27 with SSc, and 17 with SLE. CDT was assayed by the N Latex CDT immunonephelometric assay.
RESULTS:
The levels of %CDT in the sera of RA, SLE, and SSc patients were significantly higher than in controls while the absolute concentrations of CDT were unchanged. %CDT, CDT, and transferrin do not differ significantly between patients with rheumatic diseases. In RA and SSc patients, a positive correlation was observed between %CDT and C-reactive protein (CRP), as well as a positive correlation in RA patients between %CDT and 28-joint Disease Activity Score (DAS28).
CONCLUSIONS:
The changes in the serum %CDT concentration in patients with RA and SSc correlated with disease activity markers.
AuthorsE Gruszewska, A Chludzinska, L Chrostek, B Cylwik, E Gindzienska-Sieskiewicz, M Szmitkowski, S Sierakowski
JournalScandinavian journal of rheumatology (Scand J Rheumatol) Vol. 42 Issue 3 Pg. 203-6 ( 2013) ISSN: 1502-7732 [Electronic] England
PMID23379548 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Biomarkers
  • Transferrin
  • carbohydrate-deficient transferrin
Topics
  • Adult
  • Aged
  • Arthritis, Rheumatoid (blood)
  • Biomarkers (blood)
  • Female
  • Humans
  • Lupus Erythematosus, Systemic (blood)
  • Middle Aged
  • Scleroderma, Systemic (blood)
  • Transferrin (analogs & derivatives, metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: